Firstly, we observed the survival time of mice after CP CAR-T cell treatment was significantly prolonged than that of mice processed with c-Met CAR-T cells, which may benefit from its superior tumor suppressor effects and the potential effects of disturbing PD-1/PD-L1 combination (Figure 4E). The gene discussed is CP; the disease is neoplasm.